Epiretinal membrane (ERM) is a common condition that affects the eyes of millions of people worldwide. It is a thin, transparent layer of tissue that forms on the surface of the retina, the light-sensitive layer of tissue at the back of the eye. ERM can cause a variety of vision problems, including blurred vision, reduced contrast sensitivity, and difficulty with night vision. In some cases, ERM can lead to permanent vision loss. Despite its prevalence, the exact cause of ERM is still not fully understood. In this article, we will explore the current understanding of ERM and discuss the latest advances in diagnosis and treatment.
Epiretinal membrane is a thin, transparent layer of tissue that forms on the surface of the retina. It is composed of collagen and other proteins, and is usually caused by the contraction of scar tissue that forms after a retinal tear or detachment. In some cases, ERM can be caused by an inflammatory process or a reaction to a surgical procedure. ERM can cause a variety of vision problems, including blurred vision, reduced contrast sensitivity, and difficulty with night vision. In some cases, ERM can lead to permanent vision loss.
ERM is typically diagnosed using a combination of physical examination, imaging tests, and other diagnostic techniques. During the physical examination, the doctor will look for signs of ERM, such as a retinal tear or detachment. Imaging tests, such as optical coherence tomography (OCT) and fluorescein angiography, can also be used to diagnose ERM. OCT is a non-invasive imaging technique that uses light to create detailed images of the retina. OCT can be used to detect the presence of ERM, as well as to evaluate the extent of the condition. Fluorescein angiography is a specialized imaging technique that uses a dye to highlight areas of the retina that are affected by ERM.
The treatment of ERM depends on the severity of the condition. In mild cases, treatment may not be necessary. However, in more severe cases, treatment may be necessary to prevent vision loss. The most common treatment for ERM is a surgical procedure called vitrectomy. During this procedure, the vitreous gel that fills the eye is removed and replaced with a gas or silicone oil bubble. This helps to reduce the tension on the retina and prevent further damage. In some cases, medications may be used to reduce inflammation and improve vision. Corticosteroids, such as prednisone, may be prescribed to reduce inflammation and improve vision.
Epiretinal membrane is a common condition that affects the eyes of millions of people worldwide. It is a thin, transparent layer of tissue that forms on the surface of the retina, the light-sensitive layer of tissue at the back of the eye. ERM can cause a variety of vision problems, including blurred vision, reduced contrast sensitivity, and difficulty with night vision. In some cases, ERM can lead to permanent vision loss. Diagnosis of ERM typically involves a combination of physical examination, imaging tests, and other diagnostic techniques. Treatment of ERM depends on the severity of the condition and may include surgery, medications, or a combination of both. With the latest advances in diagnosis and treatment, doctors are now better equipped to diagnose and treat ERM and help patients preserve their vision.
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.
3.
Long-term study links chronic conditions in midlife to higher cancer risk and mortality
4.
Subcutaneous Cancer Immunotherapies Provide New Options for Physicians and Patients
5.
When does a melanoma metastasize? Implications for management
1.
Unlocking the Mysteries of Reticulocyte Counts: A Guide to Understanding Your Blood Results
2.
The Checkpoint Architect: Unraveling the Mechanisms of PD-L1 Regulation for the Next Generation of Small-Molecule Therapies
3.
Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025
4.
Genetic Testing in Cancer Prevention: BRCA Mutations and Lynch Syndrome Unlocked
5.
Transforming Cancer Care: CAR T-Cell Therapy for Relapsed/Refractory NHL and ALL
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
4.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation